# FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer

Source: https://onco.cc/trials/nct06519370/  
OnCo record `nct06519370` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial testing FDA018-ADC in triple-negative breast cancer, active and no longer recruiting.

## Summary

FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer is a phase 3 interventional study registered as NCT06519370, led by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, and active but no longer recruiting on the registry. Official title: A Phase 3, Open-label, Randomised Study of FDA018-ADC Versus Investigator's Choice of Chemotherapy in Patients Who Recurred During or After Taxane Therapy in Locally Advanced or Metastatic Triple-negative Breast Cancer. Planned enrolment is 350 participants (estimated). The study started in 2024-08-09 and primary completion is expected in 2026-08-18. No results have been posted on ClinicalTrials.gov.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-11
- Tags: ctgov-ingest
- Registry id: NCT06519370
- Phase: 3
- Setting: A Phase 3, Open-label, Randomised Study of FDA018-ADC Versus Investigator's Choice of Chemotherapy in Patients Who Recurred During or After Taxane Therapy in Locally Advanced or Metastatic Triple-negative Breast Cancer
- Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- Enrolled: 350

## Sources

- ClinicalTrials.gov NCT06519370: https://clinicaltrials.gov/study/NCT06519370

## Connected records

- cancers: [Metastatic triple-negative breast cancer](https://onco.cc/cancers/tnbc-metastatic/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- drugs: [FDA018-ADC](https://onco.cc/drugs/fda018-adc/)
- institutions: [Fudan University Shanghai Cancer Center](https://onco.cc/institutions/fuscc/)

---
JSON: https://onco.cc/api/v1/entities/nct06519370.json